331 related articles for article (PubMed ID: 38275516)
1. Epigallocatechin-3-Gallate and Genistein for Decreasing Gut Dysbiosis, Inhibiting Inflammasomes, and Aiding Autophagy in Alzheimer's Disease.
Muraleedharan A; Ray SK
Brain Sci; 2024 Jan; 14(1):. PubMed ID: 38275516
[TBL] [Abstract][Full Text] [Related]
2. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C
Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
Nagu P; Parashar A; Behl T; Mehta V
J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
[TBL] [Abstract][Full Text] [Related]
4. Nano-Honokiol ameliorates the cognitive deficits in TgCRND8 mice of Alzheimer's disease via inhibiting neuropathology and modulating gut microbiota.
Qu C; Li QP; Su ZR; Ip SP; Yuan QJ; Xie YL; Xu QQ; Yang W; Huang YF; Xian YF; Lin ZX
J Adv Res; 2022 Jan; 35():231-243. PubMed ID: 35024199
[TBL] [Abstract][Full Text] [Related]
5. Patchouli alcohol attenuates the cognitive deficits in a transgenic mouse model of Alzheimer's disease via modulating neuropathology and gut microbiota through suppressing C/EBPβ/AEP pathway.
Xu QQ; Su ZR; Yang W; Zhong M; Xian YF; Lin ZX
J Neuroinflammation; 2023 Jan; 20(1):19. PubMed ID: 36717922
[TBL] [Abstract][Full Text] [Related]
6. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin gallate-derived carbonized polymer dots: A multifunctional scavenger targeting Alzheimer's β-amyloid plaques.
Lin X; Liu W; Dong X; Sun Y
Acta Biomater; 2023 Feb; 157():524-537. PubMed ID: 36503076
[TBL] [Abstract][Full Text] [Related]
8. Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer's Disease.
Zhu F; Li C; Chu F; Tian X; Zhu J
Front Aging Neurosci; 2020; 12():544235. PubMed ID: 33132894
[TBL] [Abstract][Full Text] [Related]
9. Life Experience Matters: Enrichment and Stress Can Influence the Likelihood of Developing Alzheimer's Disease via Gut Microbiome.
Torraville SE; Flynn CM; Kendall TL; Yuan Q
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509523
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota and Immunotherapy for Alzheimer's Disease.
Dai CL; Liu F; Iqbal K; Gong CX
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499564
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Gut Microbe Dysbiosis on the Pathogenesis of Alzheimer's Disease (AD) and Related Conditions.
Nafady MH; Sayed ZS; Abdelkawy DA; Shebl ME; Elsayed RA; Ashraf GM; Perveen A; Attia MS; Bahbah EI
Curr Alzheimer Res; 2022; 19(4):274-284. PubMed ID: 35440296
[TBL] [Abstract][Full Text] [Related]
12. Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer's Disease.
Shukla PK; Delotterie DF; Xiao J; Pierre JF; Rao R; McDonald MP; Khan MM
Cells; 2021 Apr; 10(4):. PubMed ID: 33916001
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.
Shabbir U; Arshad MS; Sameen A; Oh DH
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988
[TBL] [Abstract][Full Text] [Related]
14. Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders.
Zheng Y; Bonfili L; Wei T; Eleuteri AM
Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960284
[TBL] [Abstract][Full Text] [Related]
15. The Oral-Gut-Brain AXIS: The Influence of Microbes in Alzheimer's Disease.
Narengaowa ; Kong W; Lan F; Awan UF; Qing H; Ni J
Front Cell Neurosci; 2021; 15():633735. PubMed ID: 33935651
[TBL] [Abstract][Full Text] [Related]
16. Injection of amyloid-β to lateral ventricle induces gut microbiota dysbiosis in association with inhibition of cholinergic anti-inflammatory pathways in Alzheimer's disease.
Qian XH; Liu XL; Chen G; Chen SD; Tang HD
J Neuroinflammation; 2022 Sep; 19(1):236. PubMed ID: 36171620
[TBL] [Abstract][Full Text] [Related]
17. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.
Goyal D; Ali SA; Singh RK
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110112. PubMed ID: 32949638
[TBL] [Abstract][Full Text] [Related]
18. Emerging role of gut microbiota dysbiosis in neuroinflammation and neurodegeneration.
Solanki R; Karande A; Ranganathan P
Front Neurol; 2023; 14():1149618. PubMed ID: 37255721
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment.
Liu S; Gao J; Zhu M; Liu K; Zhang HL
Mol Neurobiol; 2020 Dec; 57(12):5026-5043. PubMed ID: 32829453
[TBL] [Abstract][Full Text] [Related]
20. Do the Bugs in Your Gut Eat Your Memories? Relationship between Gut Microbiota and Alzheimer's Disease.
Borsom EM; Lee K; Cope EK
Brain Sci; 2020 Nov; 10(11):. PubMed ID: 33153085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
